News

Afatinib is an oral, once-daily, tyrosine kinase inhibitor which is being investigated for various tumor types including non-small cell lung (NSCL), breast, head and neck, and colorectal cancers

The new company will continue to provide electronic health records (EHR), practice management and revenue cycle management products. Vitera specializes in products including Intergy, Intergy EHR, Practice Analytics,

The Marketing & Publishing Services business unit is part of the Wolters’ Health & Pharma Solutions division. Marketing & Publishing Services provides business intelligence, strategic marketing and publishing

Both the companies have jointly developed ARQ 092 by utlizing ArQule Kinase Inhibitor Platform (AKIP) technology, as per the agreement signed in November 2008. Daiichi Sankyo will retain

In the trial, patients with COPD were allowed to administer nebulized RPL554 as a single dose of 0.018 mg/kg. The study met its primary endpoint by showing that

Cloe PK facilitates drug discovery and agrochemical industries’ scientists to use ADME and physicochemical data to predict human and rodent pharmacokinetics. The prediction allows drugs to be ranked

A major ingredient in the product known as ‘indispensable biochemical partner of insulin,’ stimulates the activity of insulin, thereby helping in glucose and fat metabolism, besides breaking down

The solutions offered by the company will help meet basic, applied, and clinical research demands, providing unique in vitro assays. The company also supports research and development of

The multidisciplinary Symyx Notebook helps in moving therapeutic substances and related information from research through development to early manufacturing using efficient, validated and compliant processes. The notebook which